Showing results (61-70 of 279) with videos related to
Sort By:
Pageof 28
Inflammatory Intestinal Diseases|June 8, 2019
A Patient with KL-6 Elevation with Anti-TNFα Who Could Receive Long-Term Use without Interstitial Pneumonia after Class Switch of Anti-TNFαTakuya Masuda, Atsushi Yoshida, Fumiaki Ueno, et al.Inflammatory Intestinal Diseases|May 22, 2019
Bariatric Surgery Is a Safe and Effective Option for Patients with Inflammatory Bowel Diseases: A Case Series and Systematic Review of the LiteratureJoshua L Hudson, Edward L Barnes, Hans H Herfarth, et al.Inflammatory Intestinal Diseases|May 22, 2019
Increased Prevalence of Esophageal Eosinophilia in Patients with Inflammatory Bowel DiseaseY Claire Fan, David Steele, Bharati Kochar, et al.Inflammatory Intestinal Diseases|May 22, 2019
Subclinical Nasal and Lung Lymphocytosis in Ulcerative ColitisMaurizio Marvisi, Laura Balzarini, Chiara Mancini, et al.Inflammatory Intestinal Diseases|November 1, 2021
High Serum Creatine Kinase Levels in Infliximab and Vedolizumab-Treated Inflammatory Bowel Disease PatientsManuel Sutter, Petr Hruz, Jan Hendrik NiessInflammatory Intestinal Diseases|January 27, 2022
Behcet's Disease: An In-Depth Review about Pathogenesis, Gastrointestinal Manifestations, and ManagementAnthony Nguyen, Shubhra Upadhyay, Muhammad Ali Javaid, et al.Inflammatory Intestinal Diseases|September 18, 2018
The Management of Inflammatory Bowel Disease in Elderly: Current Evidence and Future PerspectivesIan Arnott, Gerhard Rogler, Jonas HalfvarsonInflammatory Intestinal Diseases|September 18, 2018
Eribulin Does Not Prevent Epithelial-to-Mesenchymal Transition in HT-29 Intestinal Epithelial CellsMartin Leutenegger, Ramona Bruckner, Marianne R Spalinger, et al.Inflammatory Intestinal Diseases|September 18, 2018
Efficacy and Safety of Dose Escalation to Adalimumab 80 mg Every Other Week in Japanese Patients with Crohn's Disease Who Lost Response to Maintenance TherapySatoshi Motoya, Mamoru Watanabe, Kori Wallace, et al.Inflammatory Intestinal Diseases|February 28, 2022
Stopping Anti-TNF in Crohn's Disease Remitters: Pros and Cons: The ProsEdouard LouisPageof 28